Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China.

Trial Profile

Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Generalised anxiety disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Nov 2011 Results published in the Chinese Medical Journal.
    • 06 Jul 2010 Registrational comment added and comment about regulatory requirement.
    • 06 Jun 2010 Patient recruitment details and results were presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum. Results of the study were not provided in the abstract.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top